期刊文献+

A型肉毒毒素注射对偏侧面肌痉挛患者生存质量的影响 被引量:1

Impact on Quality of Life of Botulinus Toxin A Injection for Hemifacial Spasm
原文传递
导出
摘要 目的:观察A型肉毒毒素(BTXA)对面肌痉挛(HFS)患者痉挛程度的改善和生存质量的影响。方法:对68例HFS患者进行局部注射BTXA,治疗前及治疗后1个月分别对患者的痉挛程度进行判定和使用世界卫生组织生存质量评定量表简表(WHOQOL-BREF)评价生存质量。结果:97.04%的HFS患者在BXTA治疗后1个月痉挛明显改善缓解,而且患者在WHOQOL-BREF的生理领域、心理领域、社会关系领域、总的健康状况和总的生存质量的评分均明显高于治疗前,差异有统计学意义(P<0.01)。结论:局部注射BTXA可迅速缓解或消除HFS患者肌肉痉挛,提高患者的生存质量。 Objective:To determine the impact on quality of life of Botulinum Toxin A(BTXA) injection for hemifacial spasm(HFS).Methods:68 patients with hemifacial spasm were treated with BTXA.The degree of spasm alleviations and the score of World Health Organization Quality of Life Scale-Brief Form Questionnaire(WHOQOL-BREF) were assessed before and one month after treatment.Results:97.04% patients of spasm were alleviated one month after treatment and the physical health composite scores,psychological health composite scores, social relationship composite scores and total health and life scores were increased significantly (P〈0. 01). Conclusion: BTXA injected locally can relieve the patients with HFS from spasm and improve their qualities of life.
出处 《华西医学》 CAS 2009年第8期1923-1925,共3页 West China Medical Journal
关键词 A型肉毒毒素 面肌痉挛 生存质量 botulinus toxin A(BTXA) hemifacial spasm quality of life
  • 相关文献

参考文献10

  • 1SCOTT AB,KENNEDY RA,STUBBS HA. Botulinum A toxic injection as a treatment for blepharospasm[J]. Arch Ophthalmol,1985,103:347-350.
  • 2COHEN DA, SAVINO P, STERN MB, et al. Botulinum injection thePapy for blepharospasm:a review and report of 75 patients[J]. Chn .Neuropharmacol, 1986,9 : 415.
  • 3JOST WH, KOHL A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm[J]. Neurol, 2001, 248:S21 -S24.
  • 4SCHANTZ EJ,JONSOS EA. Properties and use of botulinum toxin and other microtoxins in medicine[J]. Mic Rev, 1992,56:80.
  • 5SUPUTTITADA A, PHANTHUMCHINDA K, LOCHAR- ERNKUL C,et al. Hemifacial spasm:results of treatment with low dose botulinum toxin injection[J]. J Med Assoc Thail, 2004,87: 1205-1211.
  • 6SCHEIDT CE, SCHULLER B, RAYKI G, et al. Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm[J]. Neurology, 1996,47 : 43-45.
  • 7SCHNIDER P, BIRNER P, MORARU E, et al. Long-term treatment with botulinum toxin: dosage, treatment schedules and costs [J]. Wiener Klinische Wochenschrift, 1999,111 : 59-65.
  • 8郝元涛,方积乾.世界卫生组织生存质量测定量表中文版介绍及其使用说明[J].现代康复,2000,4(8):1127-1129. 被引量:1691
  • 9WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment[J]. Psychol Med, 1998,28:551-558.
  • 10钟萍,蒋毅.A型肉毒毒素治疗半侧面肌痉挛的临床疗效评价[J].现代生物医学进展,2006,6(4):44-45. 被引量:1

二级参考文献11

  • 1Scott AB,Kennedy RA,Stubbs HA.Botulinum A toxic injection as atreatment for blepharespasm[J].Arch Ophthalmol,1985,103:347-350
  • 2Cohen DA,Savino P,Stern MB,et al.Botulinum injection therapy for blepharospasm:a review and report of 75 patients[J].Chn Neuropharmacol,1986,9:415
  • 3Albert W,Kim BSJ.Management of hemifacial spasm with botulinum A toxin.In:Jankovic J,Halktt M,eds.Therapy of botulinum toxin[M].New York,Marrel Dekker,1994:353-359
  • 4Nagata S,Matsushima T,Fujii K,Fukui M,Kuromatsu C.Hemifacial spasm due to tumor,aneurysm,or arteriovenous malformation[J].Surg Neurol,1992 Sep;38(3):204-209
  • 5WH Jost and A Kohl.Botulinum toxin:evidence-based medicine criteria in blepharospam and hemifacial spasm[J].Neurol,April 1,2001; 248 Suppl 1:21-4
  • 6Schantz EJ,Jonsos EA.Properties and use of botulinum toxin and other microtoxins in medicine[J].Microbiol Reviews,1992,56:80
  • 7Scheidt C E,Schuller B,Rayki,G et al.Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm[J].Neurology,1996,47(1):43-45
  • 8Fahn S,Marsden CD,Delong MR.Advances in neurology.Dystonia[J].Philadelphia:Lippincott-Raven,1998:152-176
  • 9William G,Bradley JR.MR of the brain stem.A practical approach[J].Radioloy,1991,179:319
  • 10Orley J. Quality of Life Assessment: International Perspectives [R ]. Sprin ger Verlag Berlin Heidelberg, 1994

共引文献1690

同被引文献9

  • 1李晨军,张建设,郑维银,杨波.射频温控热凝术治疗原发性面肌痉挛[J].临床口腔医学杂志,2001,17(z1):29-30. 被引量:6
  • 2李晨军,张建设.面肌痉挛治疗进展[J].西南军医,2004,6(4):41-43. 被引量:4
  • 3Reimer J,Gilg K,Karow A,et al.Health-related quality of life in blepharospasm or hemifacial spasm.Acta Neurologica Scandinavica,2005,111 (1):64-70.
  • 4Ludman H,Choa DI.Hemifacial spasm:operative treatment.Laryngol Otol,2007,99(3):239 245.
  • 5Kenney C,Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.Journal of Neural Transmission,2008,115(4):585-591.
  • 6Cohen DA,Savino PJ,Stern MB,et al.Botulinum injection therapy for blepharospasm:a review and report of 75 patients.Clin Neuropharmacol,1986,9(5):415-418.
  • 7Reichel G,Blepharospasm I.Botulinum toxin A and the face.hyperhidrosis and botulinum toxin in dermatology. BMJ,2002,30(15):236-245.
  • 8Thussu A,Barman CR,Prabhakar S.Botulinum toxin treatment of hemifacial spasm and blepharospasm:objective response S aluation.Neurol India,2001,47(3):206-209.
  • 9潘可风,邱蔚六.从口腔医学美学角度设计——“陈旧性面瘫整形术”疗效评审数量化的初步探讨[J].临床口腔医学杂志,1991,7(2):66-68. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部